Analysis of Metformin-Associated Lactic Acidosis using the Japanese Adverse Drug Event Report Database-Reference-Cited by-同舟云学术

Analysis of Metformin-Associated Lactic Acidosis using the Japanese Adverse Drug Event Report Database

Published:2024 Issue:3 Volume:7 Page:76-80
ISSN:2434-432X
Container-title:BPB Reports
language:en
Short-container-title:

Author:

Ichihara Nanaka¹,Maezawa Mika¹,Nakao Satoshi¹²,Miyasaka Koumi¹,Hirofuji Sakiko¹,Yamashita Moe¹,Nokura Yuka¹,Matsui Kensuke¹,Uranishi Hiroaki³,Kitamura Mayumi⁴,Horibe Megumi⁴,Iguchi Kazuhiro⁵,Nakamura Mitsuhiro¹

Affiliation:

1. Laboratory of Drug Informatics, Gifu Pharmaceutical University

2. Division of Pharmacy, Kyushu University Hospital

3. Division of Pharmacy, Nara Medical University Hospital

4. Department of Nursing, School of Health Science, Asahi University

5. Laboratory of Community pharmacy, Gifu Pharmaceutical University

Publisher

Pharmaceutical Society of Japan

Link

https://www.jstage.jst.go.jp/article/bpbreports/7/3/7_76/_pdf

Reference27 articles.

1. 1) World Health Organization. “HEARTS-D: Diagnosis and management of type 2 diabetes.” <https://www.who.int/publications/i/item/who-ucn-ncd-20.1>, cited 13 February, 2024.

2. 2) Clarke P, Gray A, Adler A, Stevens R, Raikou M, Cull C, Stratton I, Holman R. Cost-effectiveness analysis of intensive blood-glucose control with metformin in overweight patients with Type II diabetes (UKPDS No. 51). Diabetologia, 44, 298–304 (2001).

3. 3) Statpeals. “Metformin-Associated Lactic Acidosis (MALA).” <https://www.ncbi.nlm.nih.gov/books/NBK580485/>, cited 13 February, 2024.

4. 4) Stang M, Wysowski DK, Butler-Jones D. Incidence of lactic acidosis in metformin users. Diabetes Care, 22, 925–927 (1999).

5. 5) Sumitomo Pharma. “Drug Interview Form Metogluco Tablets 250 mg, Tablets 500.” <https://sumitomo-pharma.jp/product/metgluco/attachment/interv.html> cited 13 February, 2024.